CDMRP Alcohol and Substance Abuse Disorders Research Program: Consortium Award

The program supports the establishment of a Consortium whose purpose is to identify, evaluate, and advance pharmacotherapies for alcohol, opioid, and other substance use disorders, with an emphasis on other co-occurring mental health conditions, through rigorous, collaborative research efforts that translate basic knowledge and early-stage clinical products into evidence-based treatments.

Funding: $11,525,000 total 

Duration: 5 years 

Research Authority due date: 3.9.24

Pre application (required) due date: 10.9.24

Full proposal due date: 24.9.24